e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Comorbid cardiovascular condition and therapy of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
It does matter which inhalative corticosteroids asthmatic patient use! Looking at ICS side effects from users perspective
P. Kuna, M. Kokot (Lodz, Warsaw, Poland)
Source:
Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Session:
Comorbid cardiovascular condition and therapy of asthma
Session type:
Thematic Poster Session
Number:
498
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Kuna, M. Kokot (Lodz, Warsaw, Poland). It does matter which inhalative corticosteroids asthmatic patient use! Looking at ICS side effects from users perspective. Eur Respir J 2008; 32: Suppl. 52, 498
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Is there a problem with oral corticosteroid use in asthma?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
How can we minimise the use of regular oral corticosteroids in asthma?
Source: Eur Respir Rev, 29 (155) 190085; 10.1183/16000617.0085-2019
Year: 2020
What to use INSTEAD of inhaled corticosteroids in COPD?
Source: Eur Respir J 2014; 44: 1391-1393
Year: 2014
Stepping-down inhaled corticosteroid therapy in stable asthma: a secondary care perspective
Source: Eur Respir J 2005; 26: Suppl. 49, 277s
Year: 2005
Use of inhalation corticosteroids (ICS) in children with asthma in general practice
Source: Eur Respir J 2002; 20: Suppl. 38, 395s
Year: 2002
Predictors of adherence to inhaled corticosteroids in children with asthma and their parents in a multi-ethnic population
Source: Annual Congress 2007 - Education, communication and quality of life in childhood asthma
Year: 2007
Treatment with inhaled corticosteroids (ICS), smoking and asthma control in real clinical practice
Source: Annual Congress 2010 - Pharmacological treatment in primary care
Year: 2010
COPD: Are beliefs about inhaled medication associated with patients’ inhaler technique?
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018
Children with mild asthma: do they benefit from inhaled corticosteroids?
Source: Eur Respir J 2002; 20: 1470-1475
Year: 2002
Is it time to move away from short-acting beta-agonists in asthma management?
Source: Eur Respir J, 53 (4) 1802223; 10.1183/13993003.02223-2018
Year: 2019
What is the role of oral corticosteroids in the era of biologics in asthma?
Source: International Congress 2019 – State of the art session: Airway disease
Year: 2019
Inhaled corticosteroids in preschool asthmatics: are they effective and who benefits most?
Source: Eur Respir J 2003; 22: Suppl. 45, 534s
Year: 2003
Can smoking asthmatic subjects benefit from anti-asthmatic treatment?
Source: Eur Respir J 2007; 30: Suppl. 51, 15s
Year: 2007
Patients with underuse and overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhalation medication
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Treatment of asthma the current European perspective
Source: Annual Congress 2006 - Childhood asthma therapy: where we are now and where we need to go
Year: 2006
Persistent local side effects of inhaled corticosteroids in asthmatics; the possible role of GERD
Source: Annual Congress 2008 - Markers and triggers of asthma
Year: 2008
Poor adherence to inhaled corticosteroids in childhood asthma: Don‘t blame (only) the patient
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011
High inhaled corticosteroids adherence in childhood asthma: the role of medication beliefs
Source: Eur Respir J 2012; 40: 1072-1074
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept